Bone Therapeutics SA

Bone Therapeutics SAverified




Market Cap:


Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.[Read more]



IPO Date


Stock Exchange




The ROE as of May 2024 (TTM) for Bone Therapeutics SA (BOTHE.BR) is 751.45%

According to Bone Therapeutics SA’s latest financial reports and current stock price. The company's current ROE is 751.45%. This represents a change of Infinity% compared to the average of 0% of the last 4 quarters.

Bone Therapeutics SA (BOTHE.BR) Historical ROE (quarterly & annually)

How has BOTHE.BR ROE performed in the past?

The mean historical ROE of Bone Therapeutics SA over the last ten years is -858.51%. The current 751.45% ROE has changed -187.53% with respect to the historical average. Over the past ten years (40 quarters), BOTHE.BR's ROE was at its highest in in the September 2014 quarter at 65.14%. The ROE was at its lowest in in the December 2013 quarter at -2233.33%.

Quarterly (TTM)









Bone Therapeutics SA (BOTHE.BR) ROE by Quarter and Year

Discovering the peaks and valleys of Bone Therapeutics SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.71%

Maximum Annual ROE = 191.06%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -6733.33%

Quarterly (TTM)

Bone Therapeutics SA (BOTHE.BR) Average ROE

How has BOTHE.BR ROE performed in the past?

The current ROE of Bone Therapeutics SA (BOTHE.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Bone Therapeutics SA (BOTHE.BR) ROE vs. Peers

How is BOTHE.BR’s ROE compared to its peers?

Bone Therapeutics SA’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Bone Therapeutics SA (BOTHE.BR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Therapeutics SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bone Therapeutics SA (BOTHE.BR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bone Therapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Bone Therapeutics SA's ROE?

How is the ROE calculated for Bone Therapeutics SA (BOTHE.BR)?

What is the highest ROE for Bone Therapeutics SA (BOTHE.BR)?

What is the 3-year average ROE for Bone Therapeutics SA (BOTHE.BR)?

What is the 5-year average ROE for Bone Therapeutics SA (BOTHE.BR)?

How does the current ROE for Bone Therapeutics SA (BOTHE.BR) compare to its historical average?